After much discussion and deliberation, the American Professional Wound Care Association (APWCA) Board of Directors has made the difficult decision to RESCHEDULE the APWCA 2020 annual conference (Wound Week) originally scheduled for April 16-19, in Milwaukee, WI.
The target audience for this activity includes physicians, podiatrists, nurses, physical therapists, dietitians and others who manage wound care patients across the continuum of healthcare.
Statement of Need/Program Overview
The goal of this activity is designed to be a comprehensive course associated with concepts in the diagnosis and treatment of non-healing wounds. It is designed to be clinically relevant to daily wound care treatment and educate all providers to best practice to increase optimal patient outcomes and decrease patient morbidity.
In support of improving patient care, this activity has been planned and implemented by Cine-Med and the American Professional Wound Care Association. Cine-Med is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Ciné-Med designates this live activity for a maximum of 20 AMA PRA Category 1 Credit(s)TM.
Physicians should only claim credit commensurate with the extent of their participation in the activity.
This activity is approved for 20 contact hours for Nurses.
This activity has been planned and implemented in accordance with the standards and requirements for approval of providers of continuing education in podiatric medicine through a joint provider agreement between Ciné-Med and the American Professional Wound Care Association. Ciné-Med is approved by the Council on Podiatric Medical Education as a provider of continuing education in podiatric medicine. Ciné-Med has approved this activity for a maximum of 20 continuing education contact hours.
The Wisconsin Physical Therapy Association has certified that this activity meets the criteria for approval of Continuing Education.
This activity has been approved for 20 CE hours (CEUL049441).
Non-physicians participating in this activity will receive completion certificates verifying that the activity was designated for AMA PRA Category 1 Credit(s)TM.
Disclosure of Conflicts of Interest
Ciné-Med requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
All planners and staff for this activity have indicated that they have no financial relationships with commercial interests to disclose in regard to their participation in this continuing medical education activity.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. APWCA does not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Participants will receive an email within four (4) business days after the meeting with a link to complete the required evaluation and download certificates in PDF format.